We are a clinical-stage biopharmaceutical company developing a novel class of medicines, which we refer to as Bicycles, for diseases that are underserved by existing therapeutics.
$14.00 - $16.00
May 23, 2019
GOLDMAN SACHS & CO. LLC , PIPER JAFFRAY & CO.
To view the prospectus for BICYCLE THERAPEUTICS IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277